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Abstract 
The type I intermediate filament keratin 16 (K16) is constitutively expressed in ectoderm-derived 
appendages and is inducibly expressed in the epidermis upon barrier-compromising challenges. 
Dominantly-acting missense alleles in KRT16 are causative for pachyonychia congenita (PC), a 
genodermatosis involving debilitating palmoplantar keratoderma (PPK), nail dystrophy, oral 
lesions and, frequently, alterations in glands and hair. C57Bl/6;Krt16-/- mice develop oral lesions 
early after birth and PC-like PPK lesions as young adults. These PPK lesions have a marked 
dysregulation of skin barrier related genes and innate immunity effectors (e.g., danger-
associated molecular patterns), and are preceded by oxidative stress secondary to hypoactive 
Nrf2 signaling. These molecular features are present in PPK lesions of PC patients. Here we 
report that all components of the C57Bl/6;Krt16-/-
 
 mouse phenotype occur as well in the FVB 
strain background, albeit less severely so, a significant observation in light of variations in the 
clinical presentation of individuals harboring disease-causing mutations in the KRT16 gene. 
Introduction 
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Keratin 16 (K16), a type I intermediate filament gene and protein, is constitutively 
expressed in specific cell types in ectoderm-derived epithelial appendages (e.g., hair follicles, 
nail, glands, oral papillae etc.) and is inducibly expressed when stratified epithelia such as the 
epidermis are experiencing stress (e.g., UV exposure, wounding) or disease (e.g. psoriasis, 
carcinoma) (1). Genetic linkage analyses and DNA sequencing determined that dominantly-
acting missense alleles in KRT16 are causative for pachyonychia congenita (PC) (2), a 
genodermatosis involving painful and debilitating palmoplantar keratoderma (PPK), nail 
dystrophy, oral lesions and, frequently, alterations in glands and hair as well (3). Focal non-
epidermolytic PPK lesions, which occur at pressure points in palms and soles, involve dramatic 
epidermal thickening and hyperkeratosis and are often signficantly painful for patients. Of note, 
similar alleles in KRT16 can elicit a presentation of focal non-epidermolytic PPK in the absence 
of other lesions characteristic of PC (4), suggesting that the consequences associated with 
alterations in KRT16 are subject to modifier gene(s) effects.  
 Mice null for Krt16, originally generated in the C57Bl/6 background, develop oral lesions 
early after birth and PC-like PPK lesions as young adults (5). Follow-up studies showed that the 
lesions in footpad skin involve a gross misregulation of skin-barrier related genes, including 
Danger-Associated Molecular Patterns (DAMPs; also known as alarmins) and effectors of 
innate immunity (6), and are preceded and caused by a state of oxidative stress secondary to 
misregulation of Keap1-Nrf2 signaling (7). Several of the key features of PPK-like lesions in 
footpad skin of C57Bl/6;Krt16-/- mice are present in PPK lesions of individuals with PC (6,7). 
Here, we describe the phenotype associated with the Krt16 null allele in the FVB mouse strain 
background. This study was conducted for the primary purpose of defining the role of Krt16 in 
HPV16-induced carcinogenesis in the FVB background (see [8]) but provided an opportunity to 
assess the impact of genetic strain background on expression of the Krt16-/-
Results and Discussion 
 phenotype.  
The Krt16 null allele was transferred to the FVB strain background via six sequential 
backcrosses of C57Bl/6;Krt16+/- and wildtype FVB mice. Intercrosses between FVB;Krt16+/-  
were next conducted and the progeny analyzed. A third of FVB;Krt16-/- offspring dies within a 
day after birth, while ~50% of these mice survive to adulthood (Fig 1A), which is slightly more 
than what had been observed in the C57Bl/6 strain (by 17%; [5]). Macroscopic examination at 
postnatal day 5 (P5) reveals whitish and raised plaques (oral leukoplakia) in the posterior aspect 
of the dorsal tongue epithelium FVB;Krt16-/- mice, but not in FVB;Krt16+/- or FVB;Krt16+/+ mice 
(Fig 1B). Histologically, examination of sagittal cross sections of this area of the dorsal tongue 
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reveals a mildly thickened, disorganized and occasionally cytolytic epithelium (Fig. 1C), with a 
normal complement of oral papilla (data not shown), at P5. Immunostaining of similar tissue 
sections reveals that expression of the differentiation-related K13 (Fig. 1D) and its partner K4 
(data not shown) are unaltered, whereas that of K17 is dramatically reduced in the dorsal 
tongue epithelium of FVB;Krt16-/- mice (Fig. 1E). Altogether these observations, summarized in  
Suppl. Fig. 1, show that the survival at weaning and the character of oral lesions in FVB;Krt16-/- 
mice are similar to, but not as severe, as those previously reported for C57Bl/6;Krt16-/-
At the two months mark post-birth, surviving FVB;Krt16
 mice (5). 
-/- mice still weigh less compared 
to WT littermates (Suppl Table 1). All surviving male and female FVB;Krt16-/- mice develop PPK-
like lesions on their front paws (Fig. 2A), as we reported for C57Bl/6;Krt16-/- mice (5). Male mice 
exhibit a slightly earlier onset of PPK relative to females (average 4.67 ± 0.37 vs. 5.04 ± 0.41 
weeks; see Fig. 2D) and also exhibit a greater PPK index, a macroscopic and blinded measure 
of lesion severity, at 6 weeks of age (Fig 2, A and E). A similar sex bias for PPK onset also 
occurs in C57Bl/6;Krt16-/- mice (9). Histologically, the paw skin of FVB;Krt16-/- mice exhibit 
thickened epidermis and modest hyperkeratosis starting at four weeks (Fig. 2B) and peaking at 
eight weeks (Fig. 2C; sex-specific quantitation reported in Fig. 2F). Lesional footpad skin shows 
decreased staining for filaggrin (Fig 2H), suggesting impaired epidermal differentiation, a ~2.5 
fold increase in phosphorylated Histone H3-positive nuclei in the basal layer of FVB;Krt16-/- 
relative to FVB;Krt16+/+ epidermis, indicating a mild state of hyperproliferation (Fig. 2G), and 
cells positive for the innate immune cell marker CD11b, suggesting an inflammatory infiltrate 
(Fig. 2I). These observations are qualitatively similar to those made when characterizing 
C57Bl/6;Krt16-/-
Next we assessed some of the key molecular readouts that had been shown to be 
misregulated in footpad skin of C57Bl/6;Krt16
 mice (5) (see Suppl Fig 1).  
-/- mice. Emphasis was placed on mRNA levels for 
DAMPs (danger-associated molecular patterns; see (6)), key effectors of the glutathione-based 
antioxidant system, and of the Keap1-Nrf2 system (7). Transcript levels for Krt6a, the type II 
partner gene for Krt16 and a sensitive indicator of cell and tissue stress, and of several DAMPS 
including DefB4, S100A8, and S100A9 were markedly elevated (Fig. 2J). Additionally, the 
mRNA transcript levels for Sprr2d and SerpinB3a, which contribute to genesis of the cornified 
envelope, were also markedly elevated (Fig. 2J). Some of these findings were corroborated at 
the protein level, e.g., by western blotting for S100A8 and the activated form of IL-1β (data not 
shown). These observations suggest that while qualitatively similar, the alterations occurring in 
the skin barrier are less severe in FVB;Krt16-/- relative to C57Bl/6;Krt16-/- mice. 
Au
th
or
 M
an
us
cr
ip
t
 This article is protected by copyright. All rights reserved 
5 
 One of the key justification of this set of experiments was to assess the impact of Krt16 
loss for HPV16tg/+-induced tumorigenesis in FVB mouse skin (see (8)). FVB;Krt16+/- mice were 
thus bred to the FVB;HPVtg/+ mouse line as described (8). Remarkably, 100% of the Krt16-/-
;HPVtg/+
 In conclusion, our findings suggest that while genetic strain background does not impact 
the presentation of the Krt16 null phenotype in mouse at a qualitative level, it does influence the 
intensity of virtually all aspects of the presentation, ranging from perinatal lethality to the severity 
of oral and PPK-lesions. Differences in inflammatory responses between C57Bl/6 and FVB 
strains may account for these observations (10,11). These findings are thus consistent with the 
variable penetrance of the clinical presentation in individuals whose genome harbor mutated 
KRT16 alleles (2-4), and point to the Krt16 null mouse model as a useful resource to define the 
determinants involved. 
 mice died within two weeks after birth (Suppl Table 2). While the cause of death 
remains undefined and calls for substantive follow-up studies, the outcome of this cross is 
indicative of a strong genetic interaction between the HPV16 transgene and the Krt16 null allele.  
 
Materials and Methods 
 The methods used in this study are described under “Supplemental Materials”. 
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Legends to Figures 
Figure 1. FVB;Krt16-/- mice have increased mortality compared to WT and develop oral lesions. 
(A) Survival curve of FVB;Krt16 mice. n=31-36 mice/genotype. ** denotes p<0.01 determined by 
Log-rank test. (B) Pictures of macroscopic tongue plaques that occur in FVB;Krt16-/- mice (both 
sexes) at P5. (C) H&E staining of P5 tongues to evaluate histology of female FVB;Krt16-/- 
tongue lesions. Scale bar, 50 μm (D and E) Immunostaining for K13 and K17 in sections of 
fresh frozen tongue tissue from P5 male littermates. 
Figure 2. FVB;Krt16-/- mice develop PPK lesions. (A) Images of 6-weeks old male (right) and 
female (left) FVB;Krt16-/- mice displaying macroscopic appearance of PPK lesions compared to 
controls. (B and C) H&E staining of front paw skin sections relating histological changes in 4- 
and 8-weeks old FVB;Krt16-/- male mice. Dotted line corresponds to dermal/epidermal junction. 
Epi, epidermis; SC, stratum corneum. Scale bar, 50 μm. (D) Quantitation of PPK lesion onset in 
both sexes of FVB;Krt16-/- mice. Mice were scored as lesional when evidence of macroscopic 
lesions (waxy keratoderma) were present. n=4-5 mice/sex. (E) Quantitation of PPK lesions 
severity based on presence of waxy keratoderma on front paws of 6-week old FVB;Krt16 mice. 
n=2-4 mice/sex/genotype. (F) Sex-specific quantitation of epidermal thickness from 8-week old 
FVB;Krt16 front paws. n=2-3 mice/genotype. (G) Quantitation of proliferation (measured by P-
Histone H3 staining) in front paw skin from 8-weeks old male FVB;Krt16 mice. n=3 
mice/genotype. (H) Immunostaining for filaggrin (green) and keratin 5 (red) in front paw skin 
from 8-weeks old male FVB;Krt16 mice. (I) Immunostaining for CD11b (green) and p65 (red) in 
front paw skin from 8-weeks old male FVB;Krt16 mice. Scale bar, 50 μm. (J) Transcript levels 
for Danger Associated Molecular Patterns (DAMPs) in front paw skin from 8-week old 
FVB;Krt16 null mice relative to WT controls. * denotes p<0.05 and ** denotes p<0.01 as 
determined by unpaired 2-tailed Student’s t test on dCq values.  
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